Remedy Pharmaceuticals takes in $9 mln
Remedy Pharmaceuticals, which focuses on treating people affected by acute central nervous system conditions, has closed $9 million in funding. The investors included Vertical GP-5 LLC.
2 December 2015•2 mins read
